TERN

Terns Pharmaceuticals, Inc.

8.20 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Terns Pharmaceuticals, Inc. stock is up 38.98% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 10 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
06 Jun 14:06 18 Oct, 2024 10.00 CALL 423 1618
07 Jun 14:31 18 Oct, 2024 5.00 CALL 200 329
13 Jun 17:58 19 Jul, 2024 7.50 CALL 270 594
13 Jun 18:05 19 Jul, 2024 5.00 CALL 100 90
13 Jun 18:16 19 Jul, 2024 5.00 CALL 98 90
13 Jun 18:32 19 Jul, 2024 5.00 CALL 190 90
13 Jun 18:38 19 Jul, 2024 5.00 CALL 100 90
13 Jun 19:43 19 Jul, 2024 5.00 CALL 100 90
13 Jun 19:50 19 Jul, 2024 5.00 CALL 100 90
13 Jun 19:54 19 Jul, 2024 5.00 CALL 100 90

About Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.